On Friday, Shares of Humana Inc (NYSE:HUM), gained 1.91% to $183.51.
Allergan plc, declared a multi-year research partnership with Humana Inc. (HUM), one of the nation’s leading health and well-being companies, to explore new ideas and ways to improve the health and well-being of patients, members and their caregivers.
A main objective of the Allergan and Humana partnership is to study key issues and obtain a more comprehensive understanding of opportunities for improvement in care delivery.
“In today’s changing health care environment, it is important for various stakeholders in the healthcare system to come together to gain in-depth understanding of unmet needs and find solutions to improve patient outcomes,” said Gavin Corcoran, MD, FACP, Chief Medical Officer, Allergan. “This partnership aligns with our aim of leveraging real world data to build evidence and conduct comparative effectiveness research in partnership with health care systems to better understand unmet needs, the natural history of disease, and interventions that improve both outcomes and the quality of care delivered to patients.”
Humana Inc., together with its auxiliaries, operates as a health and well-being company. The company operates through three segments: Retail, Group, and Healthcare Services. The Retail segment provides Medicare and commercial fully-insured medical and specialty health insurance benefits, counting dental, vision, and other supplemental health and financial protection products directly to individuals.
Shares of Primero Mining Corp (NYSE:PPP), inclined 7.96% to $2.44, during its last trading session.
Primero Mining Corp., declared that it plans to release its third quarter 2015 operating and financial results before the market opens on Tuesday, November 3, 2015. A conference call will also be held on the same day at 10:00 am ET to discuss third quarter operating and financial results.
Primero Mining Corp., a precious metals producer, engages in the acquisition, exploration, development, and operation of mineral resource properties in Canada and Mexico. The company primarily explores for gold and silver.
At the end of Friday’s trade, Shares of Anthera Pharmaceuticals Inc (NASDAQ:ANTH), gained 7.71% to $6.29.
Anthera Pharmaceuticals, declared the initiation of the SOLUTION (Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in People With Cystic Fibrosis) Phase 3 clinical study evaluating the efficacy and safety of Sollpura(R) (liprotamase), a microbial derived, biotech pancreatic enzyme replacement therapy (PERT), contrast to an approved, porcine-derived, enteric-coated product for the treatment of exocrine pancreatic insufficiency (EPI).
The Phase 3 SOLUTION clinical study is a multicenter, randomized, open-label, assessor-blind, non-inferiority, active-comparator study designed to evaluate the efficacy and safety of Sollpura in people with EPI due to cystic fibrosis. This pivotal study is intended to evaluate the non-inferiority of Sollpura contrast with a commercially available PERT in a population enriched for PERT responders. The primary efficacy endpoint of this study will be comparative efficacy measured as the change in the coefficient of fat absorption (CFA) at the end of therapy.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for patients with unmet medical needs. It is developing blisibimod, a Phase III product candidate that targets B-cell activating factor associated with various B-cell mediated autoimmune diseases, counting systemic lupus erythematosus, Immunoglobulin A nephropathy, lupus nephritis, and others.
Finally, North Star Asset Management Group Inc (NYSE:NSAM), ended its last trade with 3.02% gain, and closed at $14.67.
NorthStar Realty Finance Corp., declared that its Board of Directors has authorized the repurchase of up to $500 million of its outstanding common stock.
The repurchases will occur from time to time in the open market and/or in privately negotiated transactions as market conditions permit. The authorization will expire in 12 months, unless otherwise extended by NorthStar Realty’s Board of Directors. The repurchase program will be utilized at administration’s discretion and in accordance with the requirements of the Securities and Exchange Commission. The timing and actual number of shares repurchased will depend on a variety of factors counting price, corporate requirements and other conditions.
Northstar Asset Management Group Inc. provides asset administration and other services in the United States and internationally. It also offers securitization transaction services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
